You have 9 free searches left this month | for more free features.

failed avastin

Showing 1 - 25 of 3,082

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Cancer, Solid Tumor Trial in United States (bevacizumab, quality-of-life assessment)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
  • bevacizumab
  • quality-of-life assessment
  • Chicago, Illinois
  • +3 more
Sep 4, 2019

Glioblastoma Multiforme, Glioblastoma, Glioma Trial in United States (VAL-083, Dianhydrogalactitol, Physician's Choice of

Terminated
  • Glioblastoma Multiforme
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • +3 more
  • Los Angeles, California
  • +4 more
Nov 12, 2019

Malignant Pleural Effusion Trial (bevacizumab and camrelizumab)

Not yet recruiting
  • Malignant Pleural Effusion
  • bevacizumab and camrelizumab
  • (no location specified)
Apr 8, 2022

Healthy Male Subjects Trial in Changchun (HLX04, US-Avastin®, EU-Avastin®)

Completed
  • Healthy Male Subjects
  • Changchun, Jilin, China
    The First Hospital of Jilin University
May 6, 2022

NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Arkhangel'sk, Russian Federation
  • +10 more
Dec 8, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Rectal Cancer, Lung Cancer, Ovarian Cancer Trial in Changchun (Bevacizumab injection, Bevacizumab injection(Avastin))

Completed
  • Rectal Cancer
  • +4 more
  • Bevacizumab injection
  • Bevacizumab injection(Avastin)
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Jul 25, 2022

Soft Tissue Sarcoma Adult Trial (Surufatinib)

Not yet recruiting
  • Soft Tissue Sarcoma Adult
  • (no location specified)
Oct 29, 2023

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

Not yet recruiting
  • Hepatocellular Carcinoma
  • BCLC Stage B Hepatocellular Carcinoma
  • Atezolizumab Injection
  • +2 more
  • (no location specified)
Mar 16, 2023

Ovarian Cancer Trial in Worldwide (Bevacizumab, liposomal doxorubicin, paclitaxel)

Completed
  • Ovarian Cancer
  • Bruxelles, Belgium
  • +116 more
May 5, 2022

Metastatic Colorectal Cancer Trial in Beijing (Bevacizumab, Capecitabine, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Bevacizumab
  • +4 more
  • Beijing, China
    Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 9, 2022

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Acute Ischemic Stroke Trial in Beijing (Bailout angioplasty, thrombectomy alone)

Recruiting
  • Acute Ischemic Stroke
  • Bailout angioplasty
  • thrombectomy alone
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Oct 31, 2022

Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Brain Tumors by Advanced MRI

Completed
  • Glioblastoma
  • Avastin
  • +5 more
  • Boston, Massachusetts
    Massachusetts general Hospital
Apr 6, 2022

Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

Not yet recruiting
  • Carcinoma
  • +7 more
  • XNW5004
  • Pembrolizumab 25 mg/mL Solution for Injection
  • (no location specified)
Aug 31, 2023

Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy Trial in Tianjin (Cadonilimab Injection, Ramucirumab

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
  • Cadonilimab Injection
  • Ramucirumab Injection
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
May 14, 2023

Breast Cancer, Breast Tumor, Breast Cancer Stage IV Trial in San Juan (MBQ-167)

Recruiting
  • Breast Cancer
  • +2 more
  • San Juan, Puerto Rico
    FDI Clinical Research
Oct 4, 2023

Breast Cancer Trial in China (JSKN003, Capecitabine tablets, Gemcitabine HCl for injection)

Not yet recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
  • +49 more
Oct 6, 2023

Glaucoma Trial in Cincinnati (iStent Infinite)

Recruiting
  • Glaucoma
  • iStent Infinite
  • Cincinnati, Ohio
    Glaukos Investigator Site
Sep 26, 2023

Solid Tumors Trial in Guangzhou (MASCT-I injection)

Completed
  • Solid Tumors
  • MASCT-I injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 25, 2023

Healthy Trial in Zuidlaren (MYL-1402O, US marketed Avastin(R), EU marketed Avastin(R))

Completed
  • Healthy
  • Zuidlaren, Netherlands
    PRA Health Sciences - Early Development Services
Mar 9, 2022

Soft Tissue Sarcoma Trial (Candonilimab)

Not yet recruiting
  • Soft Tissue Sarcoma
  • (no location specified)
Jun 22, 2023

Colorectal Cancer Trial (Avastin/FOLFIRI, Curcumin)

Completed
  • Colorectal Cancer
  • (no location specified)
Mar 28, 2022